IE
OPTR

Israel Englander’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Israel Englander’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-205,549
Closed -$2.59M – 4122
2013
Q3 		$2.59M Sell
205,549
-47,974
-19% -$636K 0.01% 1523
2013
Q2 		$3.67M Buy
+253,523
New +$3.69M 0.01% 1218

Israel Englander's OPTR Position: Q4 2013 in Review

Israel Englander sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 205,549 shares — an estimated $2.59M sold.

Israel Englander first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $3.67M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Israel Englander reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Israel Englander sold 205,549 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.59M.
  • Israel Englander first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Israel Englander's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $3.67M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Millennium Management's 13F filing for Q4 2013, filed 14 Feb 2014.